Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Co
Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross?
10:55am, Thursday, 07'th Aug 2025
GeneDx Holdings Corp. (WGS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, WGS's 50-day simple moving average broke out above its 2
Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)
09:30am, Wednesday, 06'th Aug 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder litigation firm, alerts investors that it is investigating whether GeneDx Holdings Corp.
GeneDx to Participate in Upcoming Investor Conferences
08:30am, Wednesday, 06'th Aug 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced that company management will participate in upcoming investor conferences.
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
12:43pm, Sunday, 03'rd Aug 2025
NEW YORK , Aug. 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Cor
NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Co
GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth
10:22am, Thursday, 31'st Jul 2025
GeneDx delivered a strong Q2 2025, with revenues and earnings beating expectations and full-year guidance raised over 10%. Revenue growth is driven by higher testing volumes, improved reimbursement ra
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group
03:30am, Thursday, 31'st Jul 2025
LOS ANGELES , July 31, 2025 /PRNewswire/ -- News provided by DJS Law Group LLP The DJS Law Group reminds investors that it is investigating claims GeneDx Holdings Corp. ("GeneDx" or "the Company") (
Why GeneDx Holdings Stock Crushed It Again Today
08:00pm, Wednesday, 30'th Jul 2025
GeneDx (WGS 12.78%) shareholders are having quite a spectacular week, and it's not over yet. On Wednesday, the company's stock soared again, notching a nearly 13% pop after the previous day's 8%-plus
GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm
05:07pm, Wednesday, 30'th Jul 2025
LOS ANGELES, July 30, 2025 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses
GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options
08:38am, Wednesday, 30'th Jul 2025
Katherine Stueland, GeneDx CEO, joins 'Squawk Box' to discuss diagnosing children with rare diseases, cost structure of the tests, the fight against rare diseases, company growth outlook, deployment o
Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options
Why GeneDx Holdings Stock Blasted 8% Higher Today
07:13pm, Tuesday, 29'th Jul 2025
The stock of genetic testing company GeneDx Holdings (WGS 8.09%) was quite the hot item on the second trading day of the week. After the company published an encouraging second-quarter earnings report
GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript
05:06pm, Tuesday, 29'th Jul 2025
GeneDx Holdings Corp. (NASDAQ:WGS ) Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ET Company Participants Katherine A. Stueland - President, CEO & Director Kevin Feeley - Chief Financial Offi
